跳至主要内容
临床试验/CTIS2024-510980-40-00
CTIS2024-510980-40-00招募中1 期

Debio 0123-SCLC-104

Debiopharm International SA0 个研究点目标入组 78 人开始时间: 2024年6月21日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
入组人数
78

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • 未提供

排除标准

  • 未提供

研究者

相似试验

招募中
1 期
A phase 1 study of oral Debio 0123 in combination with carboplatin in patients with advanced solid tumorsPatients with tumorsMedDRA version: 21.1Level: LLTClassification code: 10065147Term: Malignant solid tumor Class: 10029104MedDRA version: 21.1Level: LLTClassification code: 10065252Term: Solid tumor Class: 10029104
CTIS2024-510984-52-00Debiopharm International SA115
招募中
1 期
A PHASE I STUDY OF THE CEACAM5 x CD3 ANTIBODY NILK-2301 IN COLORECTAL CANCER
CTIS2023-508058-24-01ovImmune S.A.12
进行中(未招募)
1 期
A PHASE I STUDY OF THE CEACAM5 x CD3 ANTIBODY NILK-2301 IN COLORECTAL CANCEROCALLY ADVANCED OR METASTATIC LOW TUMOR VOLUME COLORECTAL CANCER
CTIS2023-508058-24-00ovImmune S.A.12
进行中(未招募)
1 期
A SINGLE-CENTER, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO ASSESS SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF REPEAT DOSES OF ARM210 IN HEALTHY SUBJECTS.Cardiac arrhythmiasMedDRA version: 20.0Level: HLGTClassification code: 10007521Term: Cardiac arrhythmias Class: 10007541
CTIS2023-509086-20-00Armgo Pharma Inc.8
招募中
1 期
Phase I study of AZD9592 in solid tumorsRecurrent or metastatic Head and NeckSquamous Cell Carcinoma of the oral cavity,oropharynx, hypopharynx or larynx, Locally Advanced or Metastatic Non-Small Cell Lung Cancer, Metastatic Colorectal CancerMedDRA version: 20.0Level: LLTClassification code: 10079440Term: Non-squamous non-small cell lung cancer Class: 10029104MedDRA version: 20.0Level: LLTClassification code: 10001160Term: Adenocarcinoma lung Class: 10029104MedDRA version: 21.1Level: PTClassification code: 10061873Term: Non-small cell lung cancer Class: 100000004864MedDRA version: 21.0Level: PTClassification code: 10052358Term: Colorectal cancer metastatic Class: 100000004864MedDRA version: 21.0Level: PTClassification code: 10060121Term: Squamous cell carcinoma of head and neck Class: 100000004864MedDRA version: 21.1Level: LLTClassification code: 10029514Term: Non-small cell lung cancer NOS Class: 10029104MedDRA version: 21.0Level: PTClassification code: 10041826Term: Squamous cell carcinoma of lung Class: 100000004864
CTIS2022-501570-18-00Astrazeneca AB626